Epoprostenol sodium
CAS No. 61849-14-7
Epoprostenol sodium( —— )
Catalog No. M33350 CAS No. 61849-14-7
Epoprostenol sodium (Prostaglandin I2 sodium salt) is a short-acting vasodilator, a synthetic prostacyclin, and can be used to study pulmonary hypertension and congestive heart failure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 278 | Get Quote |
|
| 5MG | 753 | Get Quote |
|
| 10MG | 1359 | Get Quote |
|
| 25MG | 3082 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEpoprostenol sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpoprostenol sodium (Prostaglandin I2 sodium salt) is a short-acting vasodilator, a synthetic prostacyclin, and can be used to study pulmonary hypertension and congestive heart failure.
-
DescriptionEpoprostenol (sodium) (Standard) is the analytical standard of Epoprostenol (sodium). This product is intended for research and analytical applications. Epoprostenol sodium (Prostaglandin I2 (sodium salt)), the synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), is registered worldwide for the treatment of Pulmonary arterial hypertension (PAH). Epoprostenol sodium is used in pulmonary hypertension and transplantation as a potent inhibitor of platelet aggregation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61849-14-7
-
Formula Weight374.45
-
Molecular FormulaC20H31NaO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCC[C@H](O)/C=C/[C@@H]1[C@]2([H])[C@@](C[C@H]1O)([H])O/C(C2)=C\CCCC([O-])=O.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Hexacosanoic acid
Hexacosanoic acid a very long-chain fatty acid is related to adrenoleukodystrophy (ALD) adrenomyeloneuropathy (AMN) and atherosclerosis.
-
Glucagon-Like Peptid...
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a potential therapeutic agent for the human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency.
-
Bovinic acid
Bovinic acid ((9Z,11E)-Octadecadienoic acid) is a conjugated linoleic acid with anticancer and anti-atherosclerotic activity and can be used to study coronary heart disease and obesity in the elderly.
Cart
sales@molnova.com